Jerrold Sendrow - 24 May 2022 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
24 May 2022
Net transactions value
+$5,805
Form type
4
Filing time
26 May 2022, 18:00:27 UTC
Previous filing
05 Jan 2022
Next filing
04 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRPX Common Stock, $0.00001 par value Purchase $5,805 +4,500 +100% $1.29 9,006 24 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.